Cardiopulmonary bypass–mediated lung ischemia–reperfusion injury: A protective role of sitaxentan

Background Cardiopulmonary bypass is widely used in cardiac surgery but often leads to lung ischemia–reperfusion injury, a major cause of morbidity and mortality. Despite advances in critical care, effective prevention remains challenging. Sitaxentan, a selective endothelin receptor antagonist, has...

Full description